Potter A M, Watmore A E, Cooke P, Lilleyman J S, Sokol R J
Br J Cancer. 1981 Jul;44(1):51-4. doi: 10.1038/bjc.1981.146.
One hundred and nineteen unselected and similarly treated patients with Ph1-positive chronic granulocytic leukaemia (CGL) had the precise nature of their chromosome rearrangements producing the Ph1 studied to determine whether this had any clinical relevance. Eighteen (15%) did not have the usual 9/22 translocation and these, by life-table analysis, had a significantly shorter benign phase of their disease than the others (P less than 0.01). It further appeared that possession of a non-standard Ph1 was related to age, in that whereas only 24 patients were over 60 at diagnosis, 9 (33%) had a non-9/22 translocation (P less than 0.01). As the duration of the benign phase seemed to be shorter in those over 60 irrespective of Ph1 type (P less than 0.01), the questions arose whether non-standard PhI chromosomes were simply occurring in older patients or whether they were affecting prognosis independently. Their independent effect was suggested by the 11 patients under 60 with a non-9/22 Ph1 who still had a significantly shorter benign phase than the 84 of similar age with a standard Ph1 (P less than 0.01). It is concluded that the myeloid karyotype can provide prognostic as well as diagnostic information in patients with CGL.
119例未经挑选且接受类似治疗的Ph1阳性慢性粒细胞白血病(CGL)患者,对其产生Ph1的染色体重排的确切性质进行了研究,以确定这是否具有任何临床相关性。18例(15%)没有常见的9号与22号染色体易位,通过寿命表分析,这些患者疾病的良性期明显短于其他患者(P<0.01)。进一步发现,具有非标准Ph1与年龄有关,因为诊断时只有24例患者年龄超过60岁,其中9例(33%)有非9/22易位(P<0.01)。由于无论Ph1类型如何,60岁以上患者的良性期似乎都较短(P<0.01),因此出现了这样的问题:非标准Ph1染色体是仅仅在老年患者中出现,还是它们独立影响预后。60岁以下有非9/22 Ph1的11例患者的良性期仍明显短于84例年龄相仿的有标准Ph1的患者(P<0.01),这提示了它们的独立作用。结论是,骨髓核型可为CGL患者提供预后以及诊断信息。